No Prescription |
 |
 | ||
|
TEGRETOL CR Tegretol |
|
| ||
No Prescription » Prescription Drugs 15 » TEGRETOL CR Tegretol Carbamazepine is used alone or in combination with other medications to treat certain types of seizures in patients with epilepsy. It is also used to treat trigeminal neuralgia (a condition that causes facial nerve pain). Carbamazepine extended-release capsules (Equetro brand only) are used to treat episodes of mania (frenzied abnormally excited or irritated mood) or mixed episodes (symptoms of mania and depression that happen at the same time) in patients with bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression episodes of mania and other abnormal moods). Carbamazepine is in a class of medications called anticonvulsants. It works by reducing abnormal excitement in the brain.Carbamazepine comes as a tablet a chewable tablet an extended-release (long-acting) tablet an extended-release capsule and a suspension (liquid) to take by mouth. The regular tablet chewable tablet and liquid are usually taken two to four times a day with meals. The extended-release tablet is usually taken twice a day with meals. The extended-release capsule is usually taken twice a day with or without meals. To help you remember to take carbamazepine take it at around the same times every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take carbamazepine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Swallow the extended-release tablets whole; do not split chew or crush them. The extended-release capsules may be opened and the beads inside sprinkled over food such as a teaspoon of applesauce or similar food. Do not crush or chew the extended-release capsules or the beads inside them.Shake the liquid well before each use to mix the medication evenly.Your doctor will start you on a low dose of carbamazepine and gradually increase your dose.It may take a few weeks or longer before you feel the full benefit of carbamazepine. Continue to take carbamazepine even if you feel well. Do not stop taking carbamazepine without talking to your doctor. If you have a seizure disorder and you suddenly stop taking carbamazepine your seizures may become worse. Your doctor will probably decrease your dose gradually. Buy TEGRETOL CR Tegretol and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About TEGRETOL CR Tegretol: Product Type: Prescription Drugs 15 TEGRETOL CR ( Tegretol GENERIC Carbamazepine CR ) TEGRETOL CR (Tegretol GENERIC Carbamazepine CR) Tegretol GENERIC Carbamazepine CR 200mg 200(2 x 100 Tabs-CR) 200mg 100 Tablet-CR 200mg 400(4 x 100 Tabs-CR) 400mg 400(4 x 100 Tabs-CR) 400mg 100 Tablets-CR 400mg 200(2 x 100 Tabs-CR) Tegretol GENERIC Carbamazepine CR TEGRETOL CR
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
